338 related articles for article (PubMed ID: 22941262)
1. Amyloid neuropathies.
Adams D; Lozeron P; Lacroix C
Curr Opin Neurol; 2012 Oct; 25(5):564-72. PubMed ID: 22941262
[TBL] [Abstract][Full Text] [Related]
2. [Treatment of familial amyloid polyneuropathy].
Adams D; Samuel D; Slama M
Presse Med; 2012 Sep; 41(9 Pt 1):793-806. PubMed ID: 22341949
[TBL] [Abstract][Full Text] [Related]
3. [Analyses of amyloid formation mechanism in familial amyloidotic polyneuropathy and therapeutic trial].
Ando Y
Rinsho Byori; 2000 May; 48(5):425-9. PubMed ID: 10892290
[TBL] [Abstract][Full Text] [Related]
4. [Familial amyloid polyneuropathies: therapeutic issues].
Adams D; Cauquil C; Théaudin M
Bull Acad Natl Med; 2012 Oct; 196(7):1333-45; discussion 1345-7. PubMed ID: 23815018
[TBL] [Abstract][Full Text] [Related]
5. Cardiac amyloid in patients with familial amyloid polyneuropathy consists of abundant wild-type transthyretin.
Yazaki M; Tokuda T; Nakamura A; Higashikata T; Koyama J; Higuchi K; Harihara Y; Baba S; Kametani F; Ikeda S
Biochem Biophys Res Commun; 2000 Aug; 274(3):702-6. PubMed ID: 10924339
[TBL] [Abstract][Full Text] [Related]
6. Current and future treatment of amyloid neuropathies.
Adams D; Cauquil C; Theaudin M; Rousseau A; Algalarrondo V; Slama MS
Expert Rev Neurother; 2014 Dec; 14(12):1437-51. PubMed ID: 25416603
[TBL] [Abstract][Full Text] [Related]
7. Risk of transmission of systemic transthyretin amyloidosis after domino liver transplantation.
Lladó L; Baliellas C; Casasnovas C; Ferrer I; Fabregat J; Ramos E; Castellote J; Torras J; Xiol X; Rafecas A
Liver Transpl; 2010 Dec; 16(12):1386-92. PubMed ID: 21117248
[TBL] [Abstract][Full Text] [Related]
8. The molecular biology and clinical features of amyloid neuropathy.
Benson MD; Kincaid JC
Muscle Nerve; 2007 Oct; 36(4):411-23. PubMed ID: 17554795
[TBL] [Abstract][Full Text] [Related]
9. Recent progress in the understanding and treatment of transthyretin amyloidosis.
Sekijima Y
J Clin Pharm Ther; 2014 Jun; 39(3):225-33. PubMed ID: 24749898
[TBL] [Abstract][Full Text] [Related]
10. Late-onset familial amyloid polyneuropathy type I (transthyretin Met30-associated familial amyloid polyneuropathy) unrelated to endemic focus in Japan. Clinicopathological and genetic features.
Misu Ki; Hattori N; Nagamatsu M; Ikeda Si; Ando Y; Nakazato M; Takei Yi; Hanyu N; Usui Y; Tanaka F; Harada T; Inukai A; Hashizume Y; Sobue G
Brain; 1999 Oct; 122 ( Pt 10)():1951-62. PubMed ID: 10506096
[TBL] [Abstract][Full Text] [Related]
11. Transthyretin-derived amyloid deposition on the gastric mucosa in domino recipients of familial amyloid polyneuropathy liver.
Takei Y; Gono T; Yazaki M; Ikeda S; Ikegami T; Hashikura Y; Miyagawa S; Hoshii Y
Liver Transpl; 2007 Feb; 13(2):215-8. PubMed ID: 17029284
[TBL] [Abstract][Full Text] [Related]
12. [Protein and DNA sequencing analyses of transthyretin in familial amyloidotic polyneuropathy].
Nakazato M
Rinsho Shinkeigaku; 1995 Dec; 35(12):1436-7. PubMed ID: 8752422
[TBL] [Abstract][Full Text] [Related]
13. Clusterin regulates transthyretin amyloidosis.
Lee KW; Lee DH; Son H; Kim YS; Park JY; Roh GS; Kim HJ; Kang SS; Cho GJ; Choi WS
Biochem Biophys Res Commun; 2009 Oct; 388(2):256-60. PubMed ID: 19664600
[TBL] [Abstract][Full Text] [Related]
14. [Familial amyloid polyneuropathy].
Yamashita T; Ando Y; Uchino M
Brain Nerve; 2011 Jun; 63(6):583-95. PubMed ID: 21613661
[TBL] [Abstract][Full Text] [Related]
15. [Variable clinical manifestations of familial amyloid polyneuropathy and living related liver transplantation].
Ikeda S; Yanagisawa N
Rinsho Shinkeigaku; 1995 Dec; 35(12):1433-5. PubMed ID: 8752421
[TBL] [Abstract][Full Text] [Related]
16. [Fibril-forming proteins: the amyloidosis. New hopes for a disease that cardiologists must know].
Arbustini E; Gavazzi A; Merlini G
Ital Heart J Suppl; 2002 Jun; 3(6):590-7. PubMed ID: 12116807
[TBL] [Abstract][Full Text] [Related]
17. FAP neuropathy and emerging treatments.
Adams D; Théaudin M; Cauquil C; Algalarrondo V; Slama M
Curr Neurol Neurosci Rep; 2014 Mar; 14(3):435. PubMed ID: 24482069
[TBL] [Abstract][Full Text] [Related]
18. The course and prognostic factors of familial amyloid polyneuropathy after liver transplantation.
Adams D; Samuel D; Goulon-Goeau C; Nakazato M; Costa PM; Feray C; Planté V; Ducot B; Ichai P; Lacroix C; Metral S; Bismuth H; Said G
Brain; 2000 Jul; 123 ( Pt 7)():1495-504. PubMed ID: 10869060
[TBL] [Abstract][Full Text] [Related]
19. Contribution of wild-type transthyretin to hereditary peripheral nerve amyloid.
Yazaki M; Liepnieks JJ; Kincaid JC; Benson MD
Muscle Nerve; 2003 Oct; 28(4):438-42. PubMed ID: 14506715
[TBL] [Abstract][Full Text] [Related]
20. Hereditary and acquired amyloid neuropathies.
Adams D
J Neurol; 2001 Aug; 248(8):647-57. PubMed ID: 11569892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]